![Professionally Cannabis and Psychedelics artwork](https://is4-ssl.mzstatic.com/image/thumb/Podcasts123/v4/6f/7a/4c/6f7a4cc5-56e2-8145-59cc-7194170e62c4/mza_388915466200673780.jpg/100x100bb.jpg)
Peter Crock, CEO of Cann Group
Professionally Cannabis and Psychedelics
English - September 16, 2021 13:26 - 29 minutes - 17.4 MB - ★★★★★ - 4 ratingsAlternative Health Health & Fitness Medicine cannabis weed marijuana business investing pot potstocks cannabiz psychedelics psychedelic Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Bek Muslimov & Nikolay Tretiyakov, Co-Founders of Leafy Tunnel
Next Episode: Ronan Levy, Co-Founder & Executive Chairman, Field Trip
Earlier this year, we spoke with Peter Crock, the CEO of Australian cannabis operator, Cann Group Ltd.
As the first company in Australia granted a cultivation and research license for medical cannabis, Peter talks through the current state of play in the domestic market, Cann Group’s acquisitions and expansion into Europe, R&D initiatives and how to keep shareholders happy! Tune into Peter’s episode today to find out more.
Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content at: https://contenthub.gcintelligence.com/